ABSTRACT
Diabetes Mellitus (DM) is a main cause of serious health problems such as stroke, blindness, renal failure, and amputation. Glycated hemoglobin (HbA1c) has emerged as an important biomarker for monitoring long-term glycemic management, representing average glucose levels over the previous 8-12 weeks. The World Health Organization (WHO) recommends HbA1c as the gold standard for monitoring and predicting diabetes-related problems. This review emphasizes how important it is and how accurate interpretation is required to inform therapy decisions that work.
KEYWORDS: Blood glucose, diabetes, HbA1c, long-term glycemic index
INTRODUCTION
In today’s times, Diabetes Mellitus has become the leading cause of stroke, blindness, amputation, kidney failure, etc., Within the domain of diabetes assessment and management, glycated hemoglobin (HBA1c) has emerged as a pivotal tool in assessing the glycemic function of hemoglobin. According to WHO, it is considered the gold standard test for assessing long-term glycemic control.[1,2,3] Owing to the long lifespan of erythrocytes, it also has the advantage of showcasing average glucose levels for 8–12 weeks. An Australian report also suggested that a model incorporating HBA1c is comparable to fasting plasma glucose in predicting the development of diabetic retinopathy.[4,5]
Even though HBA1C is an effective tool in testing and diagnosing, it is yet known to be influenced by the genetic variation by the genetic variation at the rs560887 locus of the glucose-6-phosphatase catalytic 2 gene (G6PC2). This shows that patients with GCK mutation have a higher chance of being diagnosed with diabetes.[6,7] Our review article aims to give a comprehensive update on the current knowledge of HbA1c concerning different complications and conditions [Table 1].
Table 1.
Comparison of HbA1c levels and associated complications across major diabetes organizations
| Organization | HbA1C Levels | Higher HBA1c value | Most severe complication |
|---|---|---|---|
| American Diabetic Association (ADA) | Normal: Below 5.7% | ≥6.5% | Diabetic Retinopathy[2] |
| Prediabetes: 5.7%–6.4% | |||
| Diabetes: 6.5% or higher | |||
| World Health Organisation (WHO) | Normal: Below 6.0% | ≥7% | Cardiovascular disorders (Myocardial Infarction)[1] |
| Prediabetes: 6.0%–6.4% | |||
| Diabetes: 6.5% or higher | |||
| International Diabetic Federation | Normal: Below 5.7% | ≥8.5% | Diabetic Neuropathy[19] |
| Prediabetes: Between 5.7% and 6.4% | |||
| Diabetes: 6.5% or higher, confirmed by at least two separate tests. | |||
| Diabetic Association of India/ICMR | Normal: Below 5.6% | ≥9% | Diabetic Ketoacidosis[2] |
| Pre-diabetes: Between 5.7% and 6.4% | |||
| Diabetes: Above 6.5% |
MATERIAL AND METHODS
A comprehensive search of the literature in PubMed, Scopus, Web of Science, and Embase database using keywords like HbA1c, Diabetes Mellitus, systemic Involvement, Diabetic neuropathy, nephropathy, retinopathy, cardiovascular system, and stroke. For recent updates, all related articles were scrutinized by reading abstracts and full texts wherever possible. The articles for the review were restricted to 2022–2024.
Measurement of HBA1c
Tanaka et al.[8] presented an electrochemical detection of HbA1c utilizing a flow immunoassay device. Hirokawa et al.[9] reported an enzyme-based system for detecting HbA1c utilizing fructose peptide oxidase. However, HbA1c (%) cannot be computed only using these approaches. To calculate HBA1c, total hemoglobin must be measured followed by computation of the HBA1c/Hb ratio. Engbaeck et al.[10] developed a direct adsorption immunoassay for HBA1c but is prone to interference with proteins. Numerous factors affect the value of HBA1c which needs to be properly interpreted through proper analysis. Drugs such as levofloxacin, penicillin, cephalosporins, vitamin E, etc. can reflect a false decrease in the value.[11,12]
Conditions associated with HBA1c
-
Diabetes Mellitus:
Various studies have demonstrated that HBA1c indicates the prognosis of microvascular problems. HbA1c is disproportionately higher in old age and in women with Symptoms like vaginal itching, unintentional weight loss, and frequent urination also tend to indicate poor glycaemic control[13,14] Sole dependency on HBA1C for diabetes assessment can lead to serious clinical errors. The glycation gap (GGap) measures the difference between calculated A1C and the value predicted by regression on fructosamine.[15,16]
-
Cardiovascular Diseases and Stroke:
HBA1c is known to be associated with the ratio of total to high-density lipoprotein and hypertension. Increasing HBA1c levels in type 2 diabetic patients and being overweight pose a greater risk of cardiovascular diseases and eventually death[17] A case-control study of 32 nations (n = 26,919) found 26% of stroke patients had diabetes versus the 22% of controls. The incidence of stroke is minimum with HBA1c levels ranging from 6% to 7%.[18]
-
Diabetic Peripheral Neuropathy:
It is one of the most common complications occurring in at least half of type 2 diabetes patients. Wang et al. found that DPN occurred in 8.4% of non-elderly and 24% of elderly. However, in the initial stages, higher HBA1c levels predicted DPN in the elderly than in the non-elderly.[19]
-
Diabetes Retinopathy:
It is one of the primary conditions causing blindness in China. Retinopathy is far more common in type 2 diabetic patients as compared to patients with normal HBA1c levels.[20]
-
Diabetic Nephropathy:
Damage to kidneys starts in the prediabetes stage but it is usually diagnosed when the patient presents with end-stage renal disease. In a recent study conducted by Arnold et al., it was concluded that HBA1c is a strong predictor of the early decline of eGFR.[21]
CONCLUSION
HBA1c measures average glucose exposure over 2–3 months. It independently predicts all-cause and cardiovascular mortality and was recently added to the diabetes screening algorithm. Increased levels of HBA1c can cause vascular stiffness, cause endothelial damage, aggravate endothelin release, and lead to vasomotor dysfunction.[22]
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
REFERENCES
- 1.Diabetes. World Health Organization. 2023. [[Last accessed on 2024 Aug 05]]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes .
- 2.What is the A1C test? American Diabetic Association. 2024. [[Last accessed on 2024 Aug 05]]. Available at: https://diabetes.org/about-diabetes/a1c .
- 3.Ram Y, Xu Y, Cheng A, Dunn T, Ajjan RA. Variation in the relationship between fasting glucose and HbA1c: implications for the diagnosis of diabetes in different age and ethnic groups. BMJ Open Diabetes Res Care. 2024;12:e003470. doi: 10.1136/bmjdrc-2023-003470. [doi: 10.1136/bmjdrc-2023-003470] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Geta ET, Terefa DR, Hailu WB, Olani W, Merdassa E, Dessalegn M, et al. Effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients: A systematic review and meta-analysis. PloS One. 2024;19:e0306296. doi: 10.1371/journal.pone.0306296. [doi: 10.1371/journal.pone.0306296] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wang J, Zhang L, Bai Y, Wang X, Wang W, Li J, et al. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7. J Diabetes. 2023;15:7–14. doi: 10.1111/1753-0407.13345. [doi: 10.1111/1753-0407.13345] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hoffman LS, Fox TJ, Anastasopoulou C, Anastasopoulou C, Jialal I. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2024. [[Last accessed on 2023 Aug 14]]. Maturity Onset Diabetes in the Young. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532900/ [PubMed] [Google Scholar]
- 7.Nakasato Y, Terashita S, Kusabiraki S, Horie S, Wada T, Nakabayashi M, et al. Glucokinase maturity-onset diabetes of the young as a mimicker of stress hyperglycemia: a case report. Clinical pediatric endocrinology: Case reports. Clin Pediatr Endocrinol. 2023;32:72–5. doi: 10.1297/cpe.2022-0024. [doi: 10.1297/cpe.2022-0024] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tanaka T, Tsukube S, Izawa K, Okochi M, Lim T, Watanabe S, et al. Electrochemical detection of HbA1c, a maker for diabetes, using a flow immunoassay system. Biosens Bioelectron. 2007;22:2051–56. doi: 10.1016/j.bios.2006.09.008. [doi: 10.1016/j.bios.2006.09.008] [DOI] [PubMed] [Google Scholar]
- 9.Hirokawa K. Enzymes used for the determination of HbA1C. FEMS Microbiology Letters. 2004;235:157–62. doi: 10.1016/j.femsle.2004.04.027. doi: 10.1016/j.femsle.2004.04.027. [DOI] [PubMed] [Google Scholar]
- 10.Engbaek F, Christensen SE, Jespersen B. Enzyme immunoassay of hemoglobin A1C: Analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia. Clin Chem. 1989;35:93–7. doi: 10.1093/clinchem/35.1.93. [PubMed] [Google Scholar]
- 11.Roy Chowdhury J, Peringeth K, Ganguly A, Necesario SR, Hsieh W, Ra Y, et al. Glycated hemoglobin (hba1c) and biofluid-based diagnosis in diabetes: A comprehensive review. J Electroanal Chem. 2024;963:118301. [doi: 10.1016/j.jelechem.2024.118301] [Google Scholar]
- 12.Chen Z, Shao L, Jiang M, Ba X, Ma B, Zhou T. Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Exp Ther Med. 2022;24:707. doi: 10.3892/etm.2022.11643. [doi: 10.3892/etm.2022.11643] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Garg P, Pethusamy K, Ranjan R. Correlation between estimated average glucose levels calculated from hba1c values and random blood glucose levels in a cohort of subjects. J Lab Physicians. 2022;15:217–223. doi: 10.1055/s-0042-1757719. [doi: 10.1055/s-0042-1757719] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sakane N, Hirota Y, Yamamoto A, Miura J, Takaike H, Hoshina S, et al. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. J Diabetes Investig. 2023;14:582–90. doi: 10.1111/jdi.13973. [doi: 10.1111/jdi.13973] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Stimson RH, Dover AR, Forbes S, Strachan MWJ, McKnight JA, Gibb FW. HbA1c Is Disproportionately Higher in Women and Older People With Type 1 Diabetes Compared With Flash Glucose Monitoring Metrics of Glycemic Control. J Diabetes Sci Technol. 2022;16:446–53. doi: 10.1177/1932296820967335. [doi: 10.1177/1932296820967335] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rodríguez-Segade S, Rodríguez J, García Lopez JM, Casanueva FF, Camiña F. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care. 2012;35:2447–50. doi: 10.2337/dc11-2450. [doi: 10.2337/dc11-2450] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pei J, Wang X, Pei Z, Hu X. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study. Cardiovasc Diabetol. 2023;22:287. doi: 10.1186/s12933-023-02026-9. [doi: 10.1186/s12933-023-02026-9] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Huang YW, Li ZP, Yin XS. Stress hyperglycemia and risk of adverse outcomes in patients with acute ischemic stroke: a systematic review and dose–response meta–analysis of cohort studies. Front Neurol. 2023;14:1219863. doi: 10.3389/fneur.2023.1219863. [doi: 10.3389/fneur.2023.1219863] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wang CS, Pai YW, Lin CH, Lee IT, Chen HH, Chang MH. Diabetic peripheral neuropathy: Age-stratified glycemic control. Front Endocrinol. 2024;15:1377923. doi: 10.3389/fendo.2024.1377923. [doi: 10.3389/fendo.2024.1377923] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhai L, Lu J, Cao X, Zhang J, Yin Y, Tian H. Association between the variability of glycated hemoglobin and retinopathy in patients with type 2 diabetes mellitus: A meta-analysis. Horm Metab Res. 2022;55:103–13. doi: 10.1055/a-1931-4400. [doi: 10.1055/a-1931-4400] [DOI] [PubMed] [Google Scholar]
- 21.Arnold F, Kappes J, Rottmann FA, Westermann L, Welte T. HbA1c-dependent projection of long-term renal outcomes. J Intern Med. 2023;295:206–15. doi: 10.1111/joim.13736. [doi: 10.1111/joim.13736] [DOI] [PubMed] [Google Scholar]
- 22.Chen S, Zhu Y, Jin S, Zhao D, Guo J, Chen L, et al. Association of glycemic control with hypertension in patients with diabetes: a population-based longitudinal study. BMC Cardiovasc Disord. 2023;23:501. doi: 10.1186/s12872-023-03478-3. [doi: 10.1186/s12872-023-03478-3] [DOI] [PMC free article] [PubMed] [Google Scholar]
